全国服务咨询热线:

18438616290

Products产品中心
首页 > 产品中心 > 生化试剂 > 小分子化合物 > abs814545DTP3 1809784-29-9

DTP3 1809784-29-9

简要描述:DTP3 1809784-29-9
DTP3 is a selective GADD45β/MKK7 inhibitor, which inhibits cancer-selective NF-κB survival pathway.

  • 产品型号:abs814545
  • 厂商性质:生产厂家
  • 更新时间:2026-02-04
  • 访  问  量:922

详细介绍

品牌absinCAS1809784-29-9
分子式C26H35N7O5纯度>98%
分子量525.6货号abs814545
规格5mg供货周期现货
主要用途is a selective GADD45β/MKK7 inhibitor应用领域化工,生物产业,农林牧渔,制药/生物制药,综合

DTP3  1809784-29-9

产品描述
描述

DTP3 is a selective GADD45β/MKK7 inhibitor, which inhibits cancer-selective NF-κB survival pathway.

纯度
>98%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
别名
DTP 3
外观
powder
可溶性/溶解性
DMSO :100 mg/mL (190.26 mM)

Water :100 mg/mL (190.26 mM)
生物活性
靶点
GADD45β,MKK7
In vitro(体外研究)
DTP3 physically interacts with MKK7, both in isolation and within the complex with GADD45β, and dissociates the GADD45β/MKK7 complex via an allosteric mechanism. DTP3 selectively kills cells and induces apoptosis in MM cells with functional MKK7 and elevated GADD45β expression without toxicity to normal cells. In addition, DTP3 displays synergistic activity with bortezomib in two different MM cell lines, exhibiting a combination index of 0.21 in U266 cells and of 0.56 in KMS-12 cells.
In vivo(体内研究)
DTP3 (14.5 mg/kg/day) exhibits potent antitumor activity against MM in mouse plasmacytoma model.
研究领域
研究领域
Drug DiscoverySmall Molecule DrugLead Compound Discovery
DTP3  1809784-29-9温馨提示:本产品仅作科研实验使用,不支持临床等研究

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
爱必信(上海)生物科技有限公司
地址:上海市浦东新区新浩路58号申江科创园18栋
邮箱:lanwu@univ-bio.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息